盛良物流(08292.HK)與水發華夏就合作開發項目訂諒解備忘錄
盛良物流(08292.HK)公佈,與水發華夏簽訂不具法律約束力諒解備忘錄,內容有關成立一間合營企業之合作項目,以開發多個項目。公司將負責引進投資者提供項目資金、爲項目投資資金提供託管服務及就項目融資提供財務意見。水發華夏則會利用其作爲國有企業的優勢,引進及倡導多個項目。
水發華夏最終控股股東爲中國山東省國有資產監督管理委員會。盛良物流指,合作能使集團可受惠水發華夏將於中國積極引進及倡導的潔淨能源及環保項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.